Sonnet BioTherapeutics Holdings, Inc.

SONN · NASDAQ
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Activities
Net Income-$7-$19-$30-$25
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$1$1
Change in WC-$2-$3$0$1
Other Non-Cash$0$0$1$0
Operating Cash Flow-$9-$21-$28-$23
Investing Activities
PP&E Inv.-$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$1-$0
Financing Activities
Debt Repay.$0-$0$0-$0
Stock Issued$4$21$2$43
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0$2$0
Financing Cash Flow$6$21$4$43
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$1-$25$20
Supplemental Information
Beg. Cash$2$3$28$7
End Cash$0$2$3$28
Free Cash Flow-$9-$22-$29-$23